Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 10 - 06 symbols : SNY save search
BioNTech and Australia’s State of Victoria Form Strategic Partnership to Establish mRNA Research Center and Manufacturing Facility
Published: 2022-10-06 (Crawled : 00:00) - globenewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -4.81%
H: 0.0%
C: -2.52%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.46%
H: 0.0%
C: 0.0%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: -0.79%
H: 1.14%
C: -1.28%
partnership research state mrna
Autoimmune Hemolytic Anemia Therapeutics Market to Record a CAGR of 9.1%, Majority of Market Growth to Originate from North America - Technavio
Published: 2022-10-06 (Crawled : 23:00) - prnewswire.com
TEVJF | $12.37 -24.22% 380
|
Health Technology
|
| O: -3.32%
H: 0.0%
C: 0.0%
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -4.81%
H: 0.0%
C: -2.52%
AZNCF | $135.305 -4.19% 1.1K
|
Health Technology
|
| O: 0.07%
H: 0.92%
C: 0.27%
VTRS | $11.095 -0.22% -0.23% 6.1M
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: -1.8%
BAX | News | $39.52 -0.13% 0.0% 2.8M
|
Health Technology
|
| O: -0.64%
H: 0.45%
C: -0.48%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.46%
H: 0.0%
C: 0.0%
AZN | $68.53 0.39% 0.39% 3.7M
|
Health Technology
|
| O: 1.55%
H: 0.79%
C: -0.65%
ARGX | $366.37 -1.16% -1.18% 270K
|
Health Technology
|
| O: -3.19%
H: 0.91%
C: -0.99%
america anemia therapeutics growth market
Global Nanomedicine Market to Reach $433.9 Billion by 2027 at a 13.46% CAGR
Published: 2022-10-06 (Crawled : 20:00) - prnewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -4.81%
H: 0.0%
C: -2.52%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -4.56%
H: 0.29%
C: 0.29%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: 0.16%
H: 0.09%
C: -0.67%
GE | $155.67 -0.7% -0.36% 6.5M
|
Electronic Technology
|
| O: -0.92%
H: 0.25%
C: -1.6%
ABT | News | $105.9 -3.03% 0.07% 12M
|
Health Technology
|
| O: 0.05%
H: 2.53%
C: -0.69%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.46%
H: 0.0%
C: 0.0%
global market
Lilly's Mounjaro is on the Fast Track Toward Potential Obesity Approval
Published: 2022-10-06 (Crawled : 16:00) - biospace.com/
MS | News 0 d | $90.08 1.06% -0.28% 9.5M
|
Finance
|
| O: -0.8%
H: 0.9%
C: -1.38%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: 0.0%
obesity approval potential
Anticipating FDA "Yes", Provention Inks Co-Promotion Deal with Sanofi for T1D Drug
Published: 2022-10-06 (Crawled : 16:00) - biospace.com/
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: 0.0%
fda drug deal sanofi
Anticipating FDA "Yes", Provention Inks Co-Promotion Deal with Sanofi for T1D...
Published: 2022-10-06 (Crawled : 15:00) - biospace.com/
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: 0.0%
fda deal sanofi
Anticoagulants Market is expected to generate a revenue of USD 56.16 Billion by 2028, Globally, at 10.20% CAGR: Verified Market Research®
Published: 2022-10-06 (Crawled : 14:20) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -2.53%
H: 0.0%
C: 0.0%
PFE A | $25.42 -1.05% -0.04% 44M
|
Health Technology
|
| O: -0.82%
H: 0.03%
C: -1.53%
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
GSK | $39.6 -0.88% 0.0% 2.8M
|
Health Technology
|
| O: -1.25%
H: 0.53%
C: -0.1%
BMY | $47.84 -0.87% -0.02% 12M
|
Health Technology
|
| O: -0.92%
H: 0.06%
C: -0.78%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: 0.0%
research expected market
Framework Solutions Launches Medical Affairs Division with Appointment of Key Executive
Published: 2022-10-06 (Crawled : 13:00) - prnewswire.com
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: 0.0%
solutions
Provention Bio to Combine Forces with Sanofi to Support Potential U.S. Launch of Teplizumab for Delay in Onset of Clinical Type 1 Diabetes (T1D) in At-Risk Individuals
Published: 2022-10-06 (Crawled : 12:00) - biospace.com/
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: 0.0%
PRVB | $24.98 0.08% 9.1M
|
Health Technology
|
| O: 24.09%
H: 0.0%
C: 0.0%
teplizumab diabetes potential sanofi
Sanofi US enters into co-promotion agreement with Provention Bio, Inc. to launch teplizumab, an investigational disease-modifying therapy for type 1 diabetes
Published: 2022-10-06 (Crawled : 12:00) - prnewswire.com
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: 0.0%
PRVB | $24.98 0.08% 9.1M
|
Health Technology
|
| O: 24.09%
H: 0.0%
C: 0.0%
diabetes agreement therapy sanofi
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.